Published ahead of print on February 22, 2007, doi:10.1164/rccm.200609-1370OC
© 2007 American Thoracic Society doi: 10.1164/rccm.200609-1370OC
Cell-based Angiopoietin-1 Gene Therapy for Acute Lung Injury1 Terrence Donnelly Research Laboratories, Division of Cardiology, St. Michael's Hospital, Toronto, Ontario, Canada; 2 Institute of Medical Science, Departments of 3 Medical Biophysics and 4 Medicine and the McLaughlin Centre for Molecular Medicine, University of Toronto, Toronto, Ontario, Canada; and 5 Molecular and Cellular Biology Research, Sunnybrook Research Institute, Toronto, Ontario, Canada Correspondence and requests for reprints should be addressed to Duncan J. Stewart, M.D., F.R.C.P.C., University of Toronto, Room 6-050k, Queen Wing, Terrence Donnelly Heart Centre, St. Michael's Hospital, 30 Bond Street, Toronto, ON, M5B 1W8 Canada. E-mail: stewartd{at}smh.toronto.on.ca Rationale: The acute respiratory distress syndrome is a significant cause of morbidity and mortality in critically ill patients. Angiopoietin-1 (Ang-1), a ligand for the endothelial Tie2 receptor, is an endothelial survival and vascular stabilization factor that reduces endothelial permeability and inhibits leukocyte–endothelium interactions. Objectives: We hypothesized that Ang-1 counteracts vascular inflammation and pulmonary vascular leak in experimental acute lung injury. Methods: We used cell-based gene therapy in a rat model of ALI. Transgenic mice overexpressing Ang-1 or deficient in the Tie2 receptor were also studied to better elucidate the mechanisms of protection. Measurements and Main Results: The present report provides data that support a strong protective role for the Ang-1/Tie2 system in two experimental models of LPS-induced acute lung injury. In a rat model, cell-based Ang-1 gene transfer improved morphological, biochemical, and molecular indices of lung injury and inflammation. These findings were confirmed in a gain-of-function conditional, targeted transgenic mouse model, in which Ang-1 reduced endothelial cell activation and the expression of adhesion molecules, associated with a marked improvement in airspace inflammation and intraalveolar septal thickening. Moreover, heterozygous Tie2-deficient mice demonstrated enhanced evidence of lung injury and increased early mortality. Conclusions: These results support a critical role for the Ang-1/Tie2 axis in modulating the pulmonary vascular response to lung injury and suggest that Ang-1 therapy may represent a potential new strategy for the treatment and/or prevention of acute respiratory distress syndrome in critically ill patients.
Key Words: acute lung injury (ALI) • acute respiratory distress syndrome (ARDS) • angiopoietin-1 • cell-based gene transfer • LPS • Tie2
This article has been cited by other articles:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
